These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7683229)

  • 21. Diffuse large-cell lymphoma of the testis.
    Tondini C; Ferreri AJ; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
    J Clin Oncol; 1999 Sep; 17(9):2854-8. PubMed ID: 10561362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.
    Schneider AM; Straus DJ; Schluger AE; Lowenthal DA; Koziner B; Lee BJ; Wong G; Clarkson BD
    J Clin Oncol; 1990 Jan; 8(1):94-102. PubMed ID: 1688617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
    Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
    Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.
    Marosi C; Heinz R; Steger G; Fortelny A; Chott A; Hanak H; Radaszkiewicz T; Baur M; Kreiner G; Schwarzinger I
    J Cancer Res Clin Oncol; 1992; 118(4):314-7. PubMed ID: 1374411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
    Mazza P; Zinzani PL; Martelli M; Fiacchini M; Bocchia M; Pileri S; Falini B; Martelli MF; Amadori S; Papa G
    Leuk Lymphoma; 1995 Feb; 16(5-6):457-63. PubMed ID: 7540460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
    Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
    J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An apparently primary lymphoma of the testicle].
    Belbusti F; Signoretti P; Tondi MR; Sparaventi G
    G Chir; 1991; 12(8-9):438-40. PubMed ID: 1721520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection.
    Taillan B; Garnier G; Ferrari E; Pesce A; Vinti H; Fuzibet JG; Dujardin P
    Acta Haematol; 1993; 89(1):10-2. PubMed ID: 7683165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
    Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
    J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different treatment strategies for diffuse large-cell lymphomas: a decision analysis.
    Djulbegovic B; Hollenberg J; Woodcock TM; Herzig R
    Med Decis Making; 1991; 11(1):1-8. PubMed ID: 1709713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Sweetenham JW; Mead GM; Whitehouse JM
    J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients.
    Broccoli A; Casadei B; Stefoni V; Pellegrini C; Quirini F; Tonialini L; Morigi A; Marangon M; Argnani L; Zinzani PL
    BMC Cancer; 2017 Apr; 17(1):276. PubMed ID: 28415982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What constitutes "improved prognosis"?
    Canellos GP
    J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic indicators in diffuse large-cell (histiocytic) lymphoma.
    Todd MB; Portlock CS; Farber LR; Holford TR; Bertino JR
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):593-601. PubMed ID: 2422144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma].
    Okubo Y; Nakazawa K
    Rinsho Ketsueki; 1993 Apr; 34(4):473-7. PubMed ID: 7685433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation.
    Koza I; Mardiak J; Bohunický L; Svancárová L; Fuchsberger P; Gyárfás J; Horák I; Spánik S; Sufliarsky J; Thalmeinerová Z
    Neoplasma; 1992; 39(1):43-7. PubMed ID: 1382234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of large-cell non-Hodgkin's lymphomas with the MACOP-B protocol].
    Montalbán C; Rodríguez García JL; Marcos Robles J; Serrano M; Arechaga S; Perales J; Bellas C
    Med Clin (Barc); 1991 Oct; 97(14):521-5. PubMed ID: 1721672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated clinical experience with MACOP-B.
    Klimo P; Connors JM
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):26-34. PubMed ID: 2438779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations.
    Connors JM; Klimo P
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):41-6. PubMed ID: 2456622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.